Clinical Trials Browser

Phase 4 × Terminated × Carcinoma, Non-Small-Cell Lung × Clear all

NCT03673332 2026-01-22

EPITOP-01

Phase 4 Terminated

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04381494 2023-06-22

ON TRAX

Phase 4 Terminated

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Pneumonia

NCT03655821 2022-05-13

IMPROVE-II

Phase 4 Terminated

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung, Delirium

NCT03460678 2020-03-05

Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03172988 2019-03-05

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02695290 2017-09-18

Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)

Phase 4 Terminated

1 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung

NCT01064050 2015-07-28

SPOC

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung